Brendan Frett

8PUBLICATIONS
28CO-AUTHORS
Biomolecular modelling and designMolecular targetsMedical infection agents (incl. prions)Organometallic chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 10, 2023
Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma.

Mason McCrury, Kennith Swafford, Sydnye L Shuttleworth

|Aug 04, 2022
FLT3 inhibitors for acute myeloid leukemia: successes, defeats, and emerging paradigms.

Baku Acharya, Debasmita Saha, Daniel Armstrong

|Feb 14, 2022
Targeting TGF-β: triumphs and challenges.

Baku Acharya, Sayem Miah, Brendan Frett

|Jan 27, 2022
Discovery of N-Trisubstituted Pyrimidine Derivatives as Type I RET and RET Gatekeeper Mutant Inhibitors with a Novel Kinase Binding Pose.

Lingtian Zhang, Marialuisa Moccia, David C Briggs

|Aug 17, 2021
Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development.

Debasmita Saha, Katie Rose Ryan, Naga Rajiv Lakkaniga

Pageof 2